113 related articles for article (PubMed ID: 33617897)
1. Cross-over Loop Cysteine C152 Acts as an Antioxidant to Maintain the Folding Stability and Deubiquitinase Activity of UCH-L1 Under Oxidative Stress.
Puri S; Hsu SD
J Mol Biol; 2021 Apr; 433(8):166879. PubMed ID: 33617897
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Puri S; Hsu SD
Biochem Biophys Res Commun; 2022 Apr; 599():57-62. PubMed ID: 35176625
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications.
Choi JE; Lee JJ; Kang W; Kim HJ; Cho JH; Han PL; Lee KJ
Mol Cell Proteomics; 2018 Sep; 17(9):1803-1823. PubMed ID: 29959188
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.
Bishop P; Rocca D; Henley JM
Biochem J; 2016 Aug; 473(16):2453-62. PubMed ID: 27515257
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.
Choi J; Levey AI; Weintraub ST; Rees HD; Gearing M; Chin LS; Li L
J Biol Chem; 2004 Mar; 279(13):13256-64. PubMed ID: 14722078
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
7. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
8. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
9. N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage.
Kim HJ; Kim HJ; Jeong JE; Baek JY; Jeong J; Kim S; Kim YM; Kim Y; Nam JH; Huh SH; Seo J; Jin BK; Lee KJ
PLoS One; 2014; 9(6):e99654. PubMed ID: 24959670
[TBL] [Abstract][Full Text] [Related]
10. The point mutation UCH-L1 C152A protects primary neurons against cyclopentenone prostaglandin-induced cytotoxicity: implications for post-ischemic neuronal injury.
Liu H; Li W; Rose ME; Hickey RW; Chen J; Uechi GT; Balasubramani M; Day BW; Patel KV; Graham SH
Cell Death Dis; 2015 Nov; 6(11):e1966. PubMed ID: 26539913
[TBL] [Abstract][Full Text] [Related]
11. Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells.
Lee JG; Baek K; Soetandyo N; Ye Y
Nat Commun; 2013; 4():1568. PubMed ID: 23463011
[TBL] [Abstract][Full Text] [Related]
12. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
Kyratzi E; Pavlaki M; Stefanis L
Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255
[TBL] [Abstract][Full Text] [Related]
13. The Knotted Protein UCH-L1 Exhibits Partially Unfolded Forms under Native Conditions that Share Common Structural Features with Its Kinetic Folding Intermediates.
Lou SC; Wetzel S; Zhang H; Crone EW; Lee YT; Jackson SE; Hsu SD
J Mol Biol; 2016 Jun; 428(11):2507-2520. PubMed ID: 27067109
[TBL] [Abstract][Full Text] [Related]
14. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-L1 plays a key role in angiogenesis by regulating hydrogen peroxide generated by NADPH oxidase 4.
Song IK; Kim HJ; Magesh V; Lee KJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):1567-1572. PubMed ID: 29128359
[TBL] [Abstract][Full Text] [Related]
16. Glutathione-mediated reversibility of covalent modification of ubiquitin carboxyl-terminal hydrolase L1 by 1,2-naphthoquinone through Cys152, but not Lys4.
Toyama T; Shinkai Y; Yazawa A; Kakehashi H; Kaji T; Kumagai Y
Chem Biol Interact; 2014 May; 214():41-8. PubMed ID: 24582816
[TBL] [Abstract][Full Text] [Related]
17. Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome.
Lee YC; Chang CY; Chen SY; Pan YR; Ho MR; Hsu SD
Sci Rep; 2017 Mar; 7():45174. PubMed ID: 28338014
[TBL] [Abstract][Full Text] [Related]
18. Structural and biochemical analyses reveal ubiquitin C-terminal hydrolase-L1 as a specific client of the peroxiredoxin II chaperone.
Lee SP; Park CM; Kim KS; Kim E; Jeong M; Shin JY; Yun CH; Kim K; Chock PB; Chae HZ
Arch Biochem Biophys; 2018 Feb; 640():61-74. PubMed ID: 29339092
[TBL] [Abstract][Full Text] [Related]
19. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
[TBL] [Abstract][Full Text] [Related]
20. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
